Needle Free Injection System Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Report ID: GMI2491

Summary Methodology

Needle Free Injection System Market is projected to experience significant growth from 2018 to 2024.

Needle free injections market size is expected to witness a significant growth due to rising incidence and prevalence of chronic diseases and increase in the number of communicable disease due to needle injuries. Needle free injection technology eliminates skin puncture hazards and problem of bleeding or bruising. Organizations such as WHO and CDC, Centre for Disease Control as well as groups like Gates Foundation are supporting the development of needle free options for drug delivery that will create immense growth opportunities in future.

Furthermore, skin being highly immunogenic, needle free injections improve immune response to vaccines. NFIT can be used for immunization of typhoid, influenza, tetanus, diphtheria, hepatitis, pertussis as well as mass immunizations such as measles and smallpox. Disposable Syringe Jet Injector Project supports clinical research studies for the delivery of vaccines using jet injectors. Hence, the rising demand for biosimilars and vaccination will further augment demand for such devices.

Needle free technologies offers very apparent benefit of minimizing needle phobia in patients. There has been a significant increase in the number of patients using self-administered drugs, in the recent past. Moreover, (CDC) Centers for Disease Control and Prevention’s, Division of Diabetes Translation (DDT) funds local as well as state health departments that support activities and programs to delay or prevent the onset of diabetes mellitus and to improve health outcomes for diabetes patients. Growing inclination towards self-administration of various drugs is a major reason that will drive the market growth, during the forecast period. 

Needle free injectors can be customized as per requirement and can be modified to optimize its productivity. However, adoption of needle free injection system can be challenging.  Moreover, high training costs and high cost of development of needle free injectors over conventional needle injection could hamper the growth of this market in the forthcoming years.

In terms of product, prefilled needle free injectors segment is expected to witness the highest CAGR during the forecast period owing to increasing prevalence of chronic diseases such as diabetes that requires accurate dose to be administered by patient.

Based on technology, jet-based injectors segment is projected to grow at the highest CAGR throughout the analysis period. These systems have additional advantages over other injectors systems such as fast drug delivery and better reproducibility resulting in enhanced bioavailability that will increase the demand for jet-based injectors.

In 2016, the liquid-based needle free injection systems segment witnessed high growth and is expected to grow in the coming years. Rising demand for biologics and technological advancements will boost the growth of liquid-based systems throughout the forecast period.

Based on site of delivery, subcutaneous injectors segment is projected to dominate the market during the analysis period owing to the increasing preference of patients towards self-administration of drugs.

Needle free injection systems offer improved bio-availability of vaccines. Owing to the increasing demand of biosimilars and vaccines, the vaccine delivery application segment is expected to witness the fastest growth during forecast period.

Based on end-use, hospitals will witness a significant growth in the forthcoming years. Rising prevalence of chronic diseases, increased healthcare expenditure as well as rising awareness about health and wellness trends will escalate growth of the hospitals and clinics segment.

U.S. dominated the needle free injection technology market in 2016 owing to increasing prevalence of chronic diseases such as diabetes, cancer and other cardiac diseases. Increasing demand of patients for self-administration of drugs and other advantages offered by needle free injections will drive the needle free injections market growth during the forecast period.

Japan is expected to witness highest growth during the forecast period due to inclination of patients towards advanced technologies, increasing demand for biologics, and increasing healthcare expenditure.

Some of the industry players include Antares Pharma, Bioject Medical Technologies, Crossject, Endo International, European Pharma Group, PharmaJet, INJEX Pharma, Medical International Technology, National Medical Products, PenJet Corporation and Valeritas. The industry players focus on strategic partnerships, mergers and collaborations as well as innovative product launches to expand their business product portfolio as main strategies. The market dynamics provides a platform to industry players to explore the high-growth areas and serve the unmet needs across different regions.

Needle Free Injection System Market by Product, 2013-2024 (USD Million)

  • Pre-filled needle free injectors
  • Fillable needle free injectors

Needle Free Injection System Market by Technology, 2013-2024 (USD Million)

  • Jet-based needle free injectors
  • Spring-based needle free injectors
  • Laser-powered needle free injectors
  • Vibration-based needle free injectors

Needle Free Injection System Market by Type of Medication, 2013-2024 (USD Million)

  • Liquid-based needle free injectors
  • Powder-based needle free injectors
  • Depot-based needle free injectors

Needle Free Injection System Market by Site of Delivery, 2013-2024 (USD Million)

  • Intradermal injectors
  • Intramuscular injectors
  • Subcutaneous injectors

Needle Free Injection System Market by Application, 2013-2024 (USD Million)

  • Vaccine delivery
  • Insulin delivery
  • Pain management
  • Pediatric injections
  • Others

Needle Free Injection System Market by Distribution Channel, 2013-2024 (USD Million)

  • Hospitals
  • Clinics
  • Homecare settings
  • Research laboratories
  • Ambulatory Surgical Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • Saudi Arabia
    • South Africa

Company Profiles:

  • Akra Dermojet
  • Antares Pharma
  • Becton Dickinson and Company
  • Bioject Medical Technologies
  • Crossject
  • Endo International
  • European Pharma Group 
  • Glide Pharma Technologies
  • INJEX Pharma
  • Inovio Pharmaceuticals
  • Lundbeck
  • Medical International Technology
  • MedImmune
  • Mystic Pharmaceuticals
  • National Medical Products
  • Optinose
  • PenJet Corporation
  • PharmaJet
  • Powderject Pharmaceuticals
  • PowderMed
  • Valeritas
  • Weston medical
  • Zogenix

What Information does this report contain?

Historical data coverage: 2013 to 2015; Growth Projections: 2016 to 2026.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Customize this Report

Pre Book Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

 Connect with our sales team

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X